Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3140610 | 0.73 | CYP2A6 (0.42) | CYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL5535496 | 0.73 | CYP1A2 (0.33) | CYP1A2CYP2A6 | |
| SCHEMBL4460819 | 0.71 | — | — | |
| SCHEMBL4467536 | 0.71 | ALDH1A1 (0.39) | CYP1A2ALDH1A1 | |
| SCHEMBL7435648 | 0.71 | TP53 (0.31) | ALDH1A1 | |
| SCHEMBL5539656 | 0.70 | KIF11 (0.33) | ALDH1A1 | |
| SCHEMBL5540987 | 0.70 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL5537475 | 0.70 | LMNA (0.33) | CYP2A6ALDH1A1 | |
| SCHEMBL2968035 | 0.68 | ALDH1A1 (0.33) | CYP1A2ALDH1A1 | |
| SCHEMBL5539117 | 0.68 | CYP1A2 (0.44) | CYP1A2CYP2A6ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115716849-A | Synthetic method of aryl phosphorus compound | 海南大学 | 2023-02-28 | — | — | CN | claimed |
| EP-1465869-B1 | MODULATORS OF LXR | EXELIXIS PATENT CO LLC (US) | 2013-05-15 | — | — | EP | claimed |
| US-7998986-B2 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS PATENT COMPANY LLC (US) | 2011-08-16 | — | — | US | claimed |
| US-20070287726-A1 | 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines | ALTANA PHARMA AG (DE) | 2007-12-13 | — | — | US | claimed |
| EP-1776361-A1 | 5-SUBSTITUTED 1H-PYRROLOÝ3,2-B¨PYRIDINES | Altana Pharma AG (DE) | 2007-04-25 | — | — | EP | claimed |
| WO-2006013195-A1 | 5-SUBSTITUTED 1H-PYRROLO[3,2-B]PYRIDINES | ALTANA PHARMA AG (DE) | 2006-02-09 | — | — | WO | claimed |
| EP-1465869-A4 | MODULATORS OF LXR | X CEPTOR THERAPEUTICS INC (US) | 2005-12-28 | — | — | EP | claimed |
| JP-2005536450-A | — | — | 2005-12-02 | — | — | JP | claimed |
| EP-1465869-A1 | MODULATORS OF LXR | X-Ceptor Therapeutics, Inc. (US) | 2004-10-13 | — | — | EP | claimed |
| CN-1152108-C | Arylheterocycle substituted naphthopyran-type photochromic compound and its preparing process and usage | 中国科学院感光化学研究所 | 2004-06-02 | — | — | CN | claimed |
| CN-1152109-C | Arylheterocycle substituted dibenzofuranpyran-type photochromic compound and its preparing process and usage | 中国科学院感光化学研究所 | 2004-06-02 | — | — | CN | claimed |
| EP-0403618-B2 | METHYL ESTERS OF ALDIMINO- OR KETIMINO-OXY-ORTHO-TOLYLACRYLIC ACID, MANUFACTURING PROCESS AND FUNGICIDES CONTAINING THEM | BAYER AG (DE) | 2004-04-28 | — | — | EP | claimed |
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | EXELIXIS, INC. | 2003-09-25 | — | — | US | claimed |
| WO-2003059884-A1 | MODULATORS OF LXR | X-CEPTOR THERAPEUTICS, INC. (US) | 2003-07-24 | — | — | WO | claimed |
| CN-1328109-A | Arylheterocycle substituted dibenzofuranpyran-type photochromic compound and its preparing process and usage | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-12-26 | — | — | CN | claimed |
| CN-1328108-A | Arylheterocycle substituted naphthopyran-type photochromic compound and its preparing process and usage | INST PHOTOSENSITIVE CHEMISTRY CAS (CN) | 2001-12-26 | — | — | CN | claimed |
| CN-1151727-A | Amino acid derivatives and their pesticidal use | BAYER AG (DE) | 1997-06-11 | — | — | CN | claimed |
| CN-115716849-A | Synthetic method of aryl phosphorus compound | 海南大学 | 2023-02-28 | — | — | CN | disclosed |
| EP-0608565-A1 | Pyridopyrimidine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1994-08-03 | — | — | EP | disclosed |
| WO-1994014809-A1 | ANELLATED URACIL DERIVATES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1994-07-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287726-A1 | 5-Substituted 1H-Pyrrolo [3,2-B] Pyridines | GIPR, VIP, PGC | CYP1A2 301/4885CYP2A6 344/4885ALDH1A1 777/4885 |
| US-20030181420-A1 | Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors | NR1H2, NR1H3, NCOA1 | CYP1A2 162/4885CYP2A6 122/4885ALDH1A1 2744/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.